These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 6814996

  • 21. Are ABVD and MOPP/ABV truly equivalent for treating Hodgkin's disease at advanced stages?
    Andrieu JM, Colonna P.
    J Clin Oncol; 1998 Jun; 16(6):2283. PubMed ID: 9626234
    [No Abstract] [Full Text] [Related]

  • 22. An elevated serum beta-2-microglobulin level is an adverse prognostic factor for overall survival in patients with early-stage Hodgkin disease.
    Chronowski GM, Wilder RB, Tucker SL, Ha CS, Sarris AH, Hagemeister FB, Barista I, Hess MA, Cabanillas F, Cox JD.
    Cancer; 2002 Dec 15; 95(12):2534-8. PubMed ID: 12467067
    [Abstract] [Full Text] [Related]

  • 23. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
    Brusamolino E, Anselmo AP, Klersy C, Santoro M, Orlandi E, Pagnucco G, Lunghi F, Maurizi-Enrici R, Baroni CD, Lazzarino M, Mandelli F, Bernasconi C.
    Haematologica; 1998 Sep 15; 83(9):812-23. PubMed ID: 9825578
    [Abstract] [Full Text] [Related]

  • 24. [The current state of curability of Hodgkin's disease].
    Streuli RA, Ultmann JE.
    Schweiz Med Wochenschr; 1981 Sep 05; 111(36):1301-3. PubMed ID: 7302531
    [Abstract] [Full Text] [Related]

  • 25. A new combination chemotherapy for recurrent Hodgkin's lymphoma.
    Rahim MA, Sarma SK, Ahmed Q.
    Bangladesh Med Res Counc Bull; 1982 Dec 05; 8(2):63-7. PubMed ID: 6897860
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease.
    Huguley CM, Durant JR, Moores RR, Chan YK, Dorfman RF, Johnson L.
    Cancer; 1975 Oct 05; 36(4):1227-40. PubMed ID: 1175125
    [Abstract] [Full Text] [Related]

  • 29. The treatment of Hodgkin's disease.
    Fairley GH.
    Trans Med Soc Lond; 1972 Oct 05; 88():61-71. PubMed ID: 4665820
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Ten-year outcomes of lymphogranulomatosis treatment according to the protocol MOPP-ABVD+radiotherapy].
    Pivnik AV, Rastrigin NA, Moiseeva TN, Lutsenko IN, Dudarova RG, Shavlokhov VS, Efimov IV, Kozhurin SV, Shitareva IV, Gemdzhian EG, Tsyba NN, Kolosova LIu, Melikian AL, Skidan NI, Pan'shin GA, Sotnikov VM, Dotsenko PV, Nechistiuk AV.
    Ter Arkh; 2006 Oct 05; 78(8):57-62. PubMed ID: 17078219
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of lymphogranulomatosis].
    Baĭsogolov GD.
    Med Radiol (Mosk); 1982 Sep 05; 27(9):83-9. PubMed ID: 6897278
    [No Abstract] [Full Text] [Related]

  • 33. MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
    Gobbi PG, Broglia C, Levis A, La Sala A, Valentino F, Chisesi T, Sacchi S, Corbella F, Cavanna L, Iannitto E, Pavone V, Molica S, Corazza GR, Federico M.
    Clin Cancer Res; 2006 Jan 15; 12(2):529-35. PubMed ID: 16428496
    [Abstract] [Full Text] [Related]

  • 34. Hodgkin's disease in renal transplant recipients.
    Doyle TJ, Venkatachalam KK, Maeda K, Saeed SM, Tilchen EJ.
    Cancer; 1983 Jan 15; 51(2):245-7. PubMed ID: 6185199
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Greater curability in advanced Hodgkin's disease?
    Portlock CS.
    Cancer J Sci Am; 1999 Jan 15; 5(5):264-5. PubMed ID: 10526665
    [No Abstract] [Full Text] [Related]

  • 37. High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas.
    Corti C, Theodore C, Bayle C, Rougier P, Nasr F, Cosset JM, Girinsky T, Hayat M, Ribrag V.
    Hematol Oncol; 1996 Dec 15; 14(4):159-63. PubMed ID: 9267461
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Polyneuropathy in patients with Hodgkin's disease and acute leukemia treated by the combined cyclic method according to the MOPP and POMP schedules].
    Klimek A, Krykowski E, Poźiak-Patewicz E.
    Pol Tyg Lek; 1976 Nov 29; 31(48):2053-5. PubMed ID: 188024
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.